Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Cancer Genetics and Cytogenetics
|
February 15, 1986
Chromosome changes in malignant mesothelioma
Z Gibas, F P Li, K H Antman, et al.
Cancer Research
|
December 3, 1999
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment
J Willuda, A Honegger, R Waibel, et al.
Cancer Treatment Reviews
|
April 17, 2007
Oncology for medical students: a European School of Oncology contribution to undergraduate cancer education
N Pavlidis, J B Vermorken, R Stahel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 6, 2011
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer
R Stahel, N Thatcher, M Früh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 29, 2015
The ESMO guideline strategy: an identity statement and reflections on improvement
G Pentheroudakis, F Cardoso, D Arnold, et al.
Surgical Oncology
|
August 17, 2010
Undergraduate training in oncology: an ESO continuing challenge for medical students
N Pavlidis, J B Vermorken, R Stahel, et al.
Cell Death and Differentiation
|
April 18, 2003
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation
S Hopkins-Donaldson, A Ziegler, S Kurtz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)
R A Joss, P Alberto, C Hürny, et al.
Cancer
|
June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center
R A Joss, K Bürki, P Dalquen, et al.
British Journal of Cancer
|
November 1, 1996
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, C Hürny, M Bacchi, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Cancer Genetics and Cytogenetics
|
February 15, 1986
Chromosome changes in malignant mesothelioma
Z Gibas, F P Li, K H Antman, et al.
Cancer Research
|
December 3, 1999
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment
J Willuda, A Honegger, R Waibel, et al.
Cancer Treatment Reviews
|
April 17, 2007
Oncology for medical students: a European School of Oncology contribution to undergraduate cancer education
N Pavlidis, J B Vermorken, R Stahel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 6, 2011
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer
R Stahel, N Thatcher, M Früh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 29, 2015
The ESMO guideline strategy: an identity statement and reflections on improvement
G Pentheroudakis, F Cardoso, D Arnold, et al.
Surgical Oncology
|
August 17, 2010
Undergraduate training in oncology: an ESO continuing challenge for medical students
N Pavlidis, J B Vermorken, R Stahel, et al.
Cell Death and Differentiation
|
April 18, 2003
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation
S Hopkins-Donaldson, A Ziegler, S Kurtz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)
R A Joss, P Alberto, C Hürny, et al.
Cancer
|
June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center
R A Joss, K Bürki, P Dalquen, et al.
British Journal of Cancer
|
November 1, 1996
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, C Hürny, M Bacchi, et al.
Page
of 8